These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7042769)

  • 41. Treatment of nocturnal enuresis with imipramine and related preparations. A double blind trial with a placebo.
    Petersen KE; Andersen OO
    Acta Paediatr Scand; 1971 Mar; 60(2):244. PubMed ID: 4926737
    [No Abstract]   [Full Text] [Related]  

  • 42. Imipramine-related tinnitus.
    Laird LK; Lydiard RB
    J Clin Psychiatry; 1989 Apr; 50(4):146. PubMed ID: 2647714
    [No Abstract]   [Full Text] [Related]  

  • 43. Response of anxiety and agitation symptoms during nefazodone treatment of major depression.
    Fawcett J; Marcus RN; Anton SF; O'Brien K; Schwiderski U
    J Clin Psychiatry; 1995; 56 Suppl 6():37-42. PubMed ID: 7649972
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Long-term safety and clinical acceptability of venlafaxine and imipramine in outpatients with major depression.
    Shrivastava RK; Cohn C; Crowder J; Davidson J; Dunner D; Feighner J; Kiev A; Patrick R
    J Clin Psychopharmacol; 1994 Oct; 14(5):322-9. PubMed ID: 7806687
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Specific responses to imipramine and doxepin in psychoneurotic depressed patients with sleep disturbance.
    Finnerty RJ; Goldberg HL
    J Clin Psychiatry; 1981 Jul; 42(7):275-9. PubMed ID: 7240113
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A preliminary study on the efficacy of sertraline and imipramine on anger attacks in atypical depression and dysthymia.
    Fava M; Nierenberg AA; Quitkin FM; Zisook S; Pearlstein T; Stone A; Rosenbaum JF
    Psychopharmacol Bull; 1997; 33(1):101-3. PubMed ID: 9133758
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical management--imipramine/placebo administration manual. NIMH Treatment of Depression Collaborative Research Program.
    Fawcett J; Epstein P; Fiester SJ; Elkin I; Autry JH
    Psychopharmacol Bull; 1987; 23(2):309-24. PubMed ID: 3303100
    [No Abstract]   [Full Text] [Related]  

  • 48. Imipramine treatment of alcoholism with comorbid depression.
    Nunes EV; McGrath PJ; Quitkin FM; Stewart JP; Harrison W; Tricamo E; Ocepek-Welikson K
    Am J Psychiatry; 1993 Jun; 150(6):963-5. PubMed ID: 8494079
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Imipramine in the treatment of depressed Alzheimer's patients: impact on cognition.
    Teri L; Reifler BV; Veith RC; Barnes R; White E; McLean P; Raskind M
    J Gerontol; 1991 Nov; 46(6):P372-7. PubMed ID: 1940094
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy in long-term treatment of depression.
    Montgomery SA
    J Clin Psychiatry; 1996; 57 Suppl 2():24-30. PubMed ID: 8626360
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Rapid antidepressant activity of melanocyte-inhibiting factor: a clinical trial.
    Levy MI; DeNigris Y; Davis KL
    Biol Psychiatry; 1982 Feb; 17(2):259-63. PubMed ID: 6122475
    [No Abstract]   [Full Text] [Related]  

  • 52. SAMe versus placebo: a double blind comparison in major depressive disorders.
    Muscettola G; Galzenati M; Balbi A
    Adv Biochem Psychopharmacol; 1982; 32():151-6. PubMed ID: 7046362
    [No Abstract]   [Full Text] [Related]  

  • 53. Comparison of electroconvulsive therapy with imipramine in endogenous depression: a double blind study.
    Gangadhar BN; Kapur RL; Kalyanasundaram S
    Br J Psychiatry; 1982 Oct; 141():367-71. PubMed ID: 6756530
    [No Abstract]   [Full Text] [Related]  

  • 54. Duration of antidepressant trials: clinical and research implications.
    Donovan SJ; Quitkin FM; Stewart JW; Ocepek-Welikson K; Harrison W; McGrath PJ; Nunes EV; Wager S; Tricamo E
    J Clin Psychopharmacol; 1994 Feb; 14(1):64-6. PubMed ID: 8151005
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Changes in behavioral ratings of depressed children treated with imipramine.
    Petti TA; Conners CK
    J Am Acad Child Psychiatry; 1983 Jul; 22(4):355-60. PubMed ID: 6348130
    [No Abstract]   [Full Text] [Related]  

  • 56. The mousetrap: managing the placebo effect in antidepressant trials.
    Lakoff A
    Mol Interv; 2002 Apr; 2(2):72-6. PubMed ID: 14993352
    [No Abstract]   [Full Text] [Related]  

  • 57. Lack of efficacy of estrogen supplementation to imipramine in resistant female depressives.
    Shapira B; Oppenheim G; Zohar J; Segal M; Malach D; Belmaker RH
    Biol Psychiatry; 1985 May; 20(5):576-9. PubMed ID: 2985131
    [No Abstract]   [Full Text] [Related]  

  • 58. Economic evaluation of paroxetine and imipramine in depressed outpatients.
    Melton ST; Kirkwood CK; Farrar TW; Brink DD; Carroll NV
    Psychopharmacol Bull; 1997; 33(1):93-100. PubMed ID: 9133757
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sociodemographic and prior clinical course characteristics associated with treatment response in depressed patients.
    Croughan JL; Secunda SK; Katz MM; Robins E; Mendels J; Swann A; Harris-Larkin B
    J Psychiatr Res; 1988; 22(3):227-37. PubMed ID: 3066896
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Depression in cancer patients. Diagnostic and treatment considerations.
    Evans DL; McCartney CF; Nemeroff CB; Haggerty JJ; Simon JS; Pedersen CA; Holmes V; Droba M; Mason GA; Raft D
    N C Med J; 1988 Oct; 49(10):546-8. PubMed ID: 3141819
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.